By Jonathan Weiss | May 17, 2013 04:23 PM EDT
The new drug will soon be submitted to the FDA for approval to treat the blood cell proliferative disorder myelofibrosis.
By Jonathan Weiss | May 13, 2013 10:21 AM EDT
With stunning results in Phase III clinical trials, the hepatitis C drug is now on a fast track for FDA approval.
By Ashik Siddique | Apr 22, 2013 08:18 PM EDT
A computer algorithm has mapped all the possible carbon-based structures in the ‘small molecule universe’ that might be created as drugs in pharmaceutical labs— even chemical compounds that don’t exist yet.
By Jonathan Weiss | Feb 05, 2013 10:05 AM EST
The FDA has taken drastic measures to increase availability of Doxil, a cancer drug that is in short supply.
